276
|
Kang H, Schmidtlein CR, Mitev K, Gerganov G, Madzhunkov Y, Humm JL, Amols HI, Kirov AS. SU-FF-I-147: Monte Carlo Based Evaluation of 3D PET Quantification Inaccuracy for the Lung. Med Phys 2009. [DOI: 10.1118/1.3181268] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
277
|
Choi C, Lee Y, Kim C, Kang H, Kim T, Lee J, Lee J, Bae D, Kim B. Phase II study of CKD602, a camptothecin analog, in combination with carboplatin for the treatment of recurrent ovarian cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.5554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5554 Background: Belotecan (Camtobell, Chong Keun Dang Corp, Seoul, Korea; CKD602) is a camptothecin derivative with anti-tumor properties recently developed. This phase II study was designed to evaluate the toxicity and efficacy of belotecan combined with carboplatin in patients with recurrent epithelial ovarian cancer (EOC). Methods: Belotecan 0.3 mg/m2/day (days 1–5) and carboplatin AUC 5 (day 5) were administered every 3 weeks for 6 cycles. Eligible patients had recurrent EOC, peritoneal serous cancer, or fallopian tube cancer. The primary objective was to determine response rate defined by Response Evaluation Criteria in Solid Tumors and CA-125 response; other end points included toxicities and progression free survival (PFS). Results: Until this preliminary analysis, sixteen patients had received the treatment and 13 patients were evaluable for response. Eight patients had platinum-sensitive disease (minimum treatment free interval≥6 months) and 6 had platinum-resistant disease (minimum treatment free interval <6 months). Overall response rate was 53.9%; there were 3 complete responses (23.1%), 4 partial responses (30.8%), 4 patients with stable disease (30.8%), and two patients with progressive disease (15.4%). Grade 3 and 4 hematologic toxicities included neutropenia (38%), thrombocytopenia (25%), and anemia (15%); there was one episode of febrile neutropenia. None of the patients experienced grades 3 and 4 gastrointestinal toxicities, including nausea, vomiting, and anorexia. Conclusions: The newly developed topoisomerase I inhibitor, belotecan (CKD-602), combined with carboplatin is a well-tolerated regimen with activity in recurrent EOC; further testing of this regimen is warranted. No significant financial relationships to disclose.
Collapse
|
278
|
Park B, Park H, Min H, Kang H, Im H, Kim S. Prediction of tumor necrosis fraction using combined volumetric and metabolic indices derived from FDG-PET/CT in osteosarcoma patients receiving neoadjuvant chemotherapy. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.10539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10539 Background: Maximum standardized uptake values (mSUV) might not reliably reflect the chemotherapy response in osteosarcoma especially when treatment response within tumors is heterogenous. The purpose of this study was to compare the usefulnesses of various FDG PET/CT indices for predicting tumor response to neoadjuvant chemotherapy and to identify the most appropriate one in osteosarcoma. Methods: Thirteen patients with primary osteosarcoma (age 14±2.9 yrs, ranged 10–19 yrs) that had undergone FDG PET/CT scans before and after neoadjuvant chemotherapy were enrolled. The authors measured mSUV, metabolic tumor volumes (MTV), and total lesion glycolysis (TLG) in each PET/CT scan. MTVs were calculated by summing voxels with SUV greater than 1.5, 2, 2.5 and 3.0, and with % mSUV greater than 20%, 25%, 30% and 35%. Histopathologic necrosis fractions were compared with the above-mentioned PET/CT parameters and their pre- to post-treatment ratios (MTV ratio, rMTV; mSUV ratio, rSUV; TLG ratio, rTLG). Results: Histopathologic necrosis fractions ranged from 3% to 99% (62.2%±37.7%). rMTV and rTLG values were found to be correlated with histopathologic necrosis fractions (R2=0.45–0.65, p<0.05), whereas, mSUV and MR image volumes (MRV), both before and after treatment, rSUV values, and rMRV values were not. With regard to rMTV and rTLG values obtained using various MTV criteria, the highest correlation was observed for a rTLG value of 2.5 mg/ml (R2=0.65, p=0.001). Five patients were classified as responders and 8 as poor-responders to neoadjuvant chemotherapy defined as those with chemotherapy-induced necrosis fractions of ≥90% and <90%, respectively. The rSUVs of responders and poor-responders were not different, but rMTV and rTLG values showed a trend toward difference, although statistically not significant (p=0.110 and 0.106, respectively). The sensitivity and specificity of rTLG were 100% and 62.5%, respectively, at an SUV cut-off of 0.13. Conclusions: In our osteosarcoma patient population, TLG and MTV, which represent combined metabolic and volumetric indices, were found to predict tumor response better than pre- or post-treatment mSUV or rSUV. No significant financial relationships to disclose.
Collapse
|
279
|
Lee S, Kim S, Kang H, Lee E, Kim E, Ko K, Kwon Y. Correlation of tumor size on preoperative breast MRI and pathologic tumor size in Asian patients. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e11546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e11546 Background: As many Asian patients want breast conserving therapy (BCT), use of magnetic resonance imaging (MRI) increase in preoperative diagnosis for breast cancer. But the impact of MRI on these patients has not been unclear. Methods: From January 2008 to July 2008, 423 patients underwent breast cancer surgery in National Cancer Center, Korea. We enrolled 357 patients consecutively in this retrospective study; 290 patients (non-MRI group) with preoperative mammography (MMG) and ultrasonography (US) vs. 66 patients (MRI group) with additional MRI to MMG, US and excluded 67 patients (42 patients with preoperative chemotherapy, 8 patients with ipsilateral recurrence, 17 patients whose MRI showed no residual lesion after excisional biopsy). We examined MRI effect on mastectomy rate, intraoperative conversion from BCT to mastectomy, positive margin rate in frozen specimen in both group. In MRI group, we evaluated the correlation between tumor size on US, MRI and pathologic tumor size. Results: Mean age of this study was 48.89 years (Non-MRI group: 50.70 years vs. MRI group: 46.33 years, p=0.001). The rate of mastectomy wasn’t different in both groups (Non-MRI group: 13.7% vs. MRI group: 19.4%, p=0.252). Intraoperative conversion to mastectomy was performed frequently in MRI group. (Non-MRI group: 1.7% vs. MRI group: 7.5%, p=0.023). But positive margin rate in frozen specimen was similar in both groups (Non-MRI group: 23.2% vs. MRI group: 34.0%, p=0.111). In MRI group, mean tumor size on MRI, US was 3.07cm, 1.98cm respectively. Mean pathologic tumor size was 2.67cm. The tumor size on MRI correlated strongly with the pathologic tumor size. The correlation coefficient was 0.732 (p=0.0001). But the tumor size on US didn’t correlate with the pathologic tumor size (p=0.066). In twenty nine patients whose MMG showed suspicious microcalcification, tumor size on MRI also correlated strongly with pathologic tumor size. The correlation coefficient was 0.693 (p=0.0001). But US didn’t show the correlation with the pathologic tumor size in these patients. Conclusions: Preoperative breast MRI didn’t give the impact on breast cancer surgery in Asian patients and could overestimate the size of tumor. But it could strongly correlate with the pathologic tumor size in Asian patients. No significant financial relationships to disclose.
Collapse
|
280
|
Min S, Jung S, Kim H, Lee S, Kim S, Kwon Y, Shin K, Kang H. 0236 Clinicopathologic features of microinvasive cancer compared with DCIS. Breast 2009. [DOI: 10.1016/s0960-9776(09)70253-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
281
|
Kim L, Eom T, Kang H, Jeon C. 0049 αB crystallin as a novel marker of lymph node metastasis in breast cancer. Breast 2009. [DOI: 10.1016/s0960-9776(09)70094-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
282
|
Kang H, Sohn S, Kim J, Park S, Hwang Y, Jang S, Kim D, Jung K. Serum Eosinophil Cationic Protein, a Useful Follow-up Marker in Baker's Asthma. J Allergy Clin Immunol 2009. [DOI: 10.1016/j.jaci.2008.12.904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
283
|
Jankowski RM, Royce ME, Lee S, Kang H, Arndt C, Rosett RL, Vagh F, Koshkin E, Wallace A. Paravertebral block for breast surgery: a cost analysis. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-6103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Abstract #6103
Background: Paravertebral block (PVB) is a form of regional block that has long been used in surgical procedures, including breast surgery. PVB provides intraoperative and postoperative analgesia, decreasing the need for narcotics (NA). It also decreases amounts of general anesthesia (GA) required. NA and GA contribute to postoperative nausea and vomiting, which is decreased with PVB. There has not been a modern cost analysis of PVB in breast surgery. The purpose of this study is to evaluate patient comfort and cost effectivness of PVB in breast surgery.
 Materials and Methods: A retrospective chart review of 461 breast cases was performed. Mastectomy with or without axillary staging and lumpectomy with axillary staging were included (n=188). Minor breast biopsies, lumpectomies alone, and combined reconstructions/other procedures were excluded. Data collected included whether or not PVB was performed (based on surgeon/patient/anesthesiologist preference), length of stay (LOS), postoperative requirements for NA and antiemetics (AE), and complications from PVB. Patients (pts) were scheduled as inpatient (IP) or outpatient (OP) based on procedure and comorbidities. The data was analyzed for IP and OP groups for LOS. Cost was calculated from NA and AE use and overnight stay.
 Results: 188 total procedures (125 IP; 63 OP). 88/125 IP had PVB (70%). 57/63 OP had PVB (90%). IP LOS < 24 hrs had 4/5 with PVB (80%); 1/5 without (20%). LOS 24-36 hrs had 46/63 with PVB (73%); 17/63 without (27%). 57 had LOS > 36 hrs; 38/57 with PVB (67%); 19/57 without (33%). OP LOS 0-2 hrs had 41 pts; 39/41 with PVB (95%); 2/41 without (5%). 22 had LOS > 2 hrs; 18/22 with PVB (82%); 4/22 without (18%). There was an overall shorter LOS for both IP and OP with PVB than without (p=0.0151). 152/188 pts required NA (81%). 112/152 received PVB (74%); 40/152 did not (26%). 36/188 did not require NA (19%). 32/36 received PVB (89%); 4/36 did not (11%). There was a difference between those who did and did not receive PVB and NA use (p=0.0257). 86/188 required antiemetics (46%). 59/86 received PVB (69%); 27/86 did not (31%). 102/188 did not require AE (54%). 86/102 received PVB (84%); 16/102 did not (16%). There was a difference between those who did and did not receive PVB and requirements for AE (p=0.0143). Number of doses of NA and AE were summarized as cost values per pt. The average cost for these medications for an IP with PVB was $184 vs $213 without. OP medicine costs with and without PVB was $39 and $111. Overall average cost difference was $29 for IP, $72 for OP. OP also saved $800 overnight charge. For all pts combined, there was a statistical cost difference (p=0.0085). 1/188 pts had a complication (pneumothorax).
 Discussion: PVB results in less use of postoperative NA and AE in breast surgery. Not only is this reflected in pt comfort, but also a statistically significant cost reduction for both IP and OP procedures and LOS.
Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 6103.
Collapse
|
284
|
Ro J, Park I, Lee K, Kang H, Kim S, Kwon Y, Lee E, Nam B. Comparable efficacies between premenopausal and postmenopausal metastatic breast cancer patients by letrozole with and without goserelin as first line hormone therapy: a phase II parallel group study. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-6134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Abstract #6134
Background: The use of goserelin in premenopausal patients(pts) is to produce castrated level of estradiol (E2), and the remaining peripheral E2 production is inhibited by letrozole, which would accomplish comparable clinical outcomes as in postmenopausal metastatic breast cancer (MBC) pts by letrozole alone.
 Methods: Hormone receptor positive pre- and postmenopausal pts with MBC were eligible. Letrozole 2.5 mg once a day was administered with goserelin 3.6 mg every 4 weeks in premenopausal pts and serial serum E2, FSH, LH were measured. Bone mineral density (BMD) and serum bone turnover markers were also checked (n=34).
 Results: Among total 78 pts enrolled, 32 pre- and 38 postmenopausal pts were assessed for efficacy and adverse events (AE). The median age was 42 years (range, 32–52) for pre- and 53 years (range, 33–70) for postmenopausal pts. Baseline characteristics were similar in the two groups, except for significantly longer disease free interval in postmenopausal pts (22.2 months vs. 41.2 months, P=0.01). Clinical benefit (CR+ PR+ SD ≥ 24 weeks) rates (62.5% vs. 68.4%, P=0.62), and objective response (CR + PR) rates (28.1 % vs. 23.7%, P=0.79) were comparable between the two groups. Median TTP was 8.6 months vs. 9.6 months (P=0.61) with a median follow-up of 11.6 months and 14.6 months, respectively. In multivariate analysis, strong ER status was significantly associated with clinical benefit rate (P=0.01), and HER2 positivity (P<0.001) and stage IV presentation (P=0.05) with shorter TTP. In premenopausal pts, the mean E2 level was dropped from 62.3 ± 81.8 pg/mL at baseline to 12.3 ± 2.2 pg/mL at week 2. AEs were mild with significantly more hot flushes in premenopausal pts. In premenopausal pts without bisphosphonate treatment, there was a trend of rising serum levels of osteocalcin (OC) (0% vs. 165%, P=0.065), bone alkaline phosphatase (bALP) (0% vs. 28%, P=0.055), and C-telopeptide (CTx) (0% vs. 108%, P=0.095), as well as a significant reduction in both lumbar spine (P=0.044) and femur (P=0.027) BMD. In contrast, in premenopausal pts with bone metastasis on bisphosphonate, there was no significant change in OC, bALP, CTx, and both BMD. In postmenopausal pts without bisphosphonate treatment, no significant change in OC, bALP, CTx, and femur BMD, while in pts with bone metastasis on bisphosphonate treatment, a significant decrease in OC (0% vs. -22%, P=0.050) and CTx (0% vs. -41%, P=0.020) and increase in both BMD (P=0.044, P=0.038 respectively) were observed.
 Conclusions: Clinical efficacies by letrozole and goserelin therapy in premenopausal MBC pts were comparable to those in postmenopausal pts by letrozole with mild AEs. While a modest increase in both bone formation and resorption especially in premenopausal pts, concurrent bisphosphonate therapy could stabilize bone metabolism in patients even with bone metastasis.
 Supported by NCC Grant No NCS-0610240-3. Letrozole for premenopausal group was supplied by Novartis.
Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 6134.
Collapse
|
285
|
Bae J, Kang H, Kim H, Park Y. Differential diagnosis of plantar wart from corn, callus and healed wart with the aid of dermoscopy. Br J Dermatol 2009; 160:220-2. [DOI: 10.1111/j.1365-2133.2008.08937.x] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
286
|
Choi C, Lee Y, Kim C, Lee E, Kang H, Kim T, Lee J, Kim B, Bae D. Experience of Laparoscopic Assisted Radical Vaginal Trachelectomy. J Minim Invasive Gynecol 2008. [DOI: 10.1016/j.jmig.2008.09.320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
287
|
Choi H, Kim K, Kim C, Kim M, Kim W, Im T, Kang H. 236: Analysis of Endotracheal Intubation Performed Using Video Laryngoscope by Emergency Physicians at Six Teaching Hospitals. Ann Emerg Med 2008. [DOI: 10.1016/j.annemergmed.2008.06.254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
288
|
Kang H, Park SG, Baek CW, Park JW, Jung YH, Woo YC, Kim JY, Koo GH. The Effect on the Recovery Profile of a Change from Enflurane to Desflurane during the Latter Part of Anaesthesia. J Int Med Res 2008; 36:951-63. [DOI: 10.1177/147323000803600511] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
This study compared emergence and recovery characteristics after either enflurane anaesthesia or crossover from enflurane to desflurane anaesthesia. At an estimated 1 h prior to the end of operation, enflurane was either reduced (group E, n = 23) or replaced with desflurane (group X, n = 23). At the end of the operation, emergence and recovery characteristics of the two groups were compared. The crossover technique accelerated recovery compared with enflurane anaesthesia. The time taken for the eyes to open in response to painful pinching or a verbal command, and to regain awareness of age and name, were significantly shorter after crossover anaesthesia than after enflurane anaesthesia. The digit symbol substitution test and serial seven test scores were significantly better in patients subjected to crossover anaesthesia than in those subjected to enflurane anaesthesia. We conclude that, during surgery, the substitution of enflurane with desflurane in the latter part of anaesthesia can improve recovery.
Collapse
|
289
|
Eisenhoffer GT, Kang H, Sánchez Alvarado A. Molecular analysis of stem cells and their descendants during cell turnover and regeneration in the planarian Schmidtea mediterranea. Cell Stem Cell 2008; 3:327-39. [PMID: 18786419 PMCID: PMC2614339 DOI: 10.1016/j.stem.2008.07.002] [Citation(s) in RCA: 288] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2008] [Revised: 06/12/2008] [Accepted: 07/02/2008] [Indexed: 12/20/2022]
Abstract
In adult planarians, the replacement of cells lost to physiological turnover or injury is sustained by the proliferation and differentiation of stem cells known as neoblasts. Neoblast lineage relationships and the molecular changes that take place during differentiation into the appropriate cell types are poorly understood. Here we report the identification and characterization of a cohort of genes specifically expressed in neoblasts and their descendants. We find that genes with severely downregulated expression after irradiation molecularly define at least three discrete subpopulations of cells. Simultaneous BrdU labeling and in situ hybridization experiments in intact and regenerating animals indicate that these cell subpopulations are related by lineage. Our data demonstrate not only the ability to measure and study the in vivo population dynamics of adult stem cells during tissue homeostasis and regeneration, but also the utility of studies in planarians to broadly inform stem cell biology in adult organisms.
Collapse
|
290
|
Ruiz R, Kang H, Detcheverry FA, Dobisz E, Kercher DS, Albrecht TR, de Pablo JJ, Nealey PF. Density Multiplication and Improved Lithography by Directed Block Copolymer Assembly. Science 2008; 321:936-9. [DOI: 10.1126/science.1157626] [Citation(s) in RCA: 1002] [Impact Index Per Article: 62.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
291
|
Rameshwar P, Corcoran KE, Greco SJ, Kang H, Patel H. Tachykinins can partly explain the link within the neuroendocrine-immune-hematopoietic axis: novel role for mesenchymal stem cells. Exp Dermatol 2008. [DOI: 10.1111/j.0906-6705.2004.00212c.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
292
|
Kang H, Yorke E, Yang J, Chui C, Rosenzweig K, Amols H. TU-EE-A1-04: Evaluation of Tumor Motion Effects On Dose Distribution for Hypofractionated Radiotherapy of Non-Small-Cell Lung Cancer. Med Phys 2008. [DOI: 10.1118/1.2962608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
293
|
Na I, Lee T, Choe D, Kang H, Koh J, Park J, Baek H, Kim C, Ryoo B, Lee J, Yang S. Factors predicting silent brain metastases in patients with non-small-cell lung cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.19131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
294
|
Lee S, Min K, Kim S, Kim S, Lee K, Kim EA, Kwon Y, Kang H, Ro J, Lee E. Effect of preoperative chemotherapy on the rate of breast conserving surgery in Korean patients with advanced breast cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.11599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
295
|
Lee M, Lee E, Ro J, Kang H, Shin K, Lee K, Chung KW, Kim S, Yun Y. Social support and depression in patients with breast cancer during 1 year from diagnosis compared with the general population. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.9612] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
296
|
Kim TH, Huh JH, Lee S, Kang H, Kim GI, An HJ. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 2008; 53:48-55. [PMID: 18479414 DOI: 10.1111/j.1365-2559.2008.03052.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
AIMS Claudin 2 (CLDN2) is a family of integral membrane tight junctions. The aim was to determine the influence of CLDN2 expression on tumour behaviour and its role in breast carcinogenesis. METHOD AND RESULTS Thirty-seven invasive breast carcinomas and corresponding normal breast tissues were examined for CLDN2 protein and mRNA expression using Western blotting and semiquantitative reverse transcriptase-polymerase chain reaction. The expression of CLDN2 protein in 118 cases of breast carcinoma was further studied with immunohistochemistry and related to various clinicopathological parameters. CLDN2 protein expression was significantly down-regulated (0.4-fold) in tumours compared with corresponding normal breast tissue (P < 0.0001). Down-regulation of CLDN2 was significantly associated with lymph node metastasis (P = 0.047) by Western blot analysis, and with high clinical stage (P = 0.040) by immunohistochemistry. The expression levels of CLDN2 mRNA in high clinical stages (stages II and III) were lower than those in low clinical stage (stage I) and normal tissue, but not statistically significantly so. CONCLUSIONS These results suggest that CLDN2 is implicated in the progression as well as the development of breast carcinoma, indicating that CLDN2 is a possible tumour suppressor gene product.
Collapse
|
297
|
Kim S, Zo J, Kim M, Lee H, Kang H, Kim H, Sohn D, Oh B, Park Y, Choi Y. EFFECT AND TOLERABILITY OF EXTENDED RELEASE TABLET OF NICOTINIC ACID IN THE MANAGEMENT OF MIXED DYSLIPIDEMIA. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70779-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
298
|
Suh J, Park J, Kim S, Kang H, Kim H, Sohn D, Oh B, Park Y, Choi Y. VKORC1 GENE POLYMORPHISM IS ASSOCIATED WITH ATHEROTHROMBOTIC COMPLICATIONS AFTER DRUG-ELUTING STENT IMPLANTATION. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70160-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
299
|
Suh J, Choi S, Park J, Kang H, Koo B, Kim Y, Oh S, Kim H, Sohn D, Oh B. THE ASSOCIATION OF ARTERIAL FUNCTION AND FUNCTIONAL POLYMORPHISMS OF RAAS IN KOREANS. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70431-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
300
|
Kang H, Pinti A, Vermeiren L, Taleb-Ahmed A, Zeng X. Tissue classification for MRI of thigh using a modified FCM method. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2008; 2007:5579-84. [PMID: 18003277 DOI: 10.1109/iembs.2007.4353611] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Fuzzy C-means (FCM) has been frequently used to image segmentation in order to separate objects. The most used segmentation attribute is grey level of pixels. Nevertheless, this method can not identify complex image objects because grey level can not take into account all visual information. This paper describes a modified FCM method for tissue classification which integrates separation and fusion operation of partition tree with expert knowledge. Our method has been applied to 26 MRI (Magnetic Resonance Imaging) images of thigh for localizing four main anatomical tissues: muscle, adipose tissue, cortical bone, and spongy bone. A testing dataset of 6500 representative points has been created by an expert. Using our method, we obtain a high classification rate (95.73%) in the test dataset, which largely improved the classification results obtained from existing methods.
Collapse
|